{"id":"W4385074099","doi":"10.1016/j.jtct.2023.07.013","title":"Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis","year":2023,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Pharmacyclics; Sanofi Genzyme; Takeda Oncology; Genentech; Health Resources and Services Administration; MorphoSys; Adaptive Biotechnologies; Astellas Pharma; bluebird bio; Kiadis Pharma; Omeros Corporation; Pfizer; Incyte; Medac; Jazz Pharmaceuticals; StemCyte; Bristol-Myers Squibb; CSL Behring; Karyopharm Therapeutics; CareDx; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Amgen; Accenture; Sanofi; GlaxoSmithKline; Seagen; Astellas Pharma US","keywords":"Medicine; Transplantation; Population; Demography; Socioeconomic status; Hematopoietic stem cell transplantation; Ethnic group; Hematopoietic cell; Cohort; Gerontology; Internal medicine; Haematopoiesis; Stem cell; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003176918,0.0001750861,0.0004131694,0.0006230728,0.00005067052,0.00003619234,0.00005996379,0.0001289554,0.00009904639],"category_scores_gemma":[0.000002138295,0.0001597395,0.00008655916,0.0003819663,0.000094797,0.0001012264,0.000004818439,0.0001473514,0.00002384179],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007214931,"about_ca_system_score_gemma":0.00006987664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004533199,"about_ca_topic_score_gemma":0.001729044,"domain_scores_codex":[0.9987486,0.0001131046,0.0003398428,0.000317225,0.0001986086,0.0002826026],"domain_scores_gemma":[0.9995526,0.0001745017,0.0000451159,0.0001186685,0.00001683914,0.00009229399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006865367,0.00009135054,0.9816716,0.0004913039,0.0001518314,0.0003400159,0.006457583,0.00005378163,0.009070219,0.00005320429,0.000001712833,0.0009309005],"study_design_scores_gemma":[0.006901245,0.0000993533,0.9850652,0.00004495407,0.0001954807,0.00001714326,0.000275124,0.0005275657,0.006634527,0.00007123314,0.000002251206,0.0001658846],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976627,0.0004447061,0.0009588996,0.0003378222,0.00003306979,0.0004010285,0.00004245569,0.00004319109,0.00007615737],"genre_scores_gemma":[0.9805722,0.01837775,0.0000414828,0.0001186655,0.00001856381,0.00004412095,0.0005643954,0.00002276582,0.0002400206],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01793305,"threshold_uncertainty_score":0.6513987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01762113482383612,"score_gpt":0.2841672491203169,"score_spread":0.2665461142964808,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}